Table 1. Characteristics of the cohort under study.
| Variable | PCa (n = 62) | Negative biopsy (n = 42) | p-value |
|---|---|---|---|
| Age (years) | 71 (64–80) | 62.5 (57.8–69) | <0.05 |
| Positive DRE | 36 (58.1%) | 0 | <0.05 |
| *Serum PSA (1) (ng/mL) | 11 (6.9–29.75) | 4.1 (3.6–5.8) | <0.05 |
| <3 | 0 | 3 (7.1%) | |
| 3–10 | 27 (43.5%) | 35 (83.3%) | |
| >10 | 35 (56.5%) | 4 (9.6%) | |
| Prostate volumen (mL) | 30 (22–40) | 27.5 (24–47) | >0.05 |
| N° biopsy (1°) | 52 (83.9%) | 38 (90.5%) | >0.05 |
| *Serum PSA (2) (ng/mL) | 11 (6.9–40.7) | 2.3 (1.8–2.7) | <0.05 |
| <3 | 0 | 41 (97.6%) | |
| 3–10 | 28 (45.2%) | 1 (2.4%) | |
| >10 | 34 (54.8%) | 0 | |
| Number of cylinders | 12 (12–13) | 12 (12–12) | >0.05 |
| Gleason pattern | |||
| 6 | 4 (6.5%) | ||
| 7 | 26 (41.9%) | ||
| ≥8 | 32 (51.6%) | ||
PSA (1): Serum PSA before the biopsy; PSA (2): Serum PSA on the day of biopsy.
*Data are expressed as median value (range of variability) (Q1-Q3).